Cargando…

Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases

The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the development of effective drugs for aging prevention is a knowledge of the biochemical pathways responsible for the cellular aging process. In this context it seems clear that free radicals play a key r...

Descripción completa

Detalles Bibliográficos
Autores principales: Camins, Antoni, Junyent, Felix, Verdaguer, Ester, Beas-Zarate, Carlos, Rojas-Mayorquín, Argelia E., Ortuño-Sahagún, Daniel, Pallàs, Mercè
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978542/
https://www.ncbi.nlm.nih.gov/pubmed/27713233
http://dx.doi.org/10.3390/ph2030194
_version_ 1782310587306344448
author Camins, Antoni
Junyent, Felix
Verdaguer, Ester
Beas-Zarate, Carlos
Rojas-Mayorquín, Argelia E.
Ortuño-Sahagún, Daniel
Pallàs, Mercè
author_facet Camins, Antoni
Junyent, Felix
Verdaguer, Ester
Beas-Zarate, Carlos
Rojas-Mayorquín, Argelia E.
Ortuño-Sahagún, Daniel
Pallàs, Mercè
author_sort Camins, Antoni
collection PubMed
description The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the development of effective drugs for aging prevention is a knowledge of the biochemical pathways responsible for the cellular aging process. In this context it seems clear that free radicals play a key role in the aging process. However, in recent years it has been demonstrated that the families of enzymes called sirtuins, specifically situin 1 (SIRT1), have an anti-aging action. Thus, the natural compound resveratrol is a natural compound that shows a very strong activation of SIRT1 and also shows antioxidant effects. By activating sirtuin 1, resveratrol modulates the activity of numerous proteins, including peroxisome proliferator-activated receptor coactivator-1α (PGC-1 alpha), the FOXO family, Akt (protein kinase B) and NFκβ. In the present review, we suggest that resveratrol may constitute a potential drug for prevention of ageing and for the treatment of several diseases due to its antioxidant properties and sirtuin activation.
format Online
Article
Text
id pubmed-3978542
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-39785422014-04-10 Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases Camins, Antoni Junyent, Felix Verdaguer, Ester Beas-Zarate, Carlos Rojas-Mayorquín, Argelia E. Ortuño-Sahagún, Daniel Pallàs, Mercè Pharmaceuticals (Basel) Review The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the development of effective drugs for aging prevention is a knowledge of the biochemical pathways responsible for the cellular aging process. In this context it seems clear that free radicals play a key role in the aging process. However, in recent years it has been demonstrated that the families of enzymes called sirtuins, specifically situin 1 (SIRT1), have an anti-aging action. Thus, the natural compound resveratrol is a natural compound that shows a very strong activation of SIRT1 and also shows antioxidant effects. By activating sirtuin 1, resveratrol modulates the activity of numerous proteins, including peroxisome proliferator-activated receptor coactivator-1α (PGC-1 alpha), the FOXO family, Akt (protein kinase B) and NFκβ. In the present review, we suggest that resveratrol may constitute a potential drug for prevention of ageing and for the treatment of several diseases due to its antioxidant properties and sirtuin activation. Molecular Diversity Preservation International 2009-12-15 /pmc/articles/PMC3978542/ /pubmed/27713233 http://dx.doi.org/10.3390/ph2030194 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Camins, Antoni
Junyent, Felix
Verdaguer, Ester
Beas-Zarate, Carlos
Rojas-Mayorquín, Argelia E.
Ortuño-Sahagún, Daniel
Pallàs, Mercè
Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
title Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
title_full Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
title_fullStr Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
title_full_unstemmed Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
title_short Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
title_sort resveratrol: an antiaging drug with potential therapeutic applications in treating diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978542/
https://www.ncbi.nlm.nih.gov/pubmed/27713233
http://dx.doi.org/10.3390/ph2030194
work_keys_str_mv AT caminsantoni resveratrolanantiagingdrugwithpotentialtherapeuticapplicationsintreatingdiseases
AT junyentfelix resveratrolanantiagingdrugwithpotentialtherapeuticapplicationsintreatingdiseases
AT verdaguerester resveratrolanantiagingdrugwithpotentialtherapeuticapplicationsintreatingdiseases
AT beaszaratecarlos resveratrolanantiagingdrugwithpotentialtherapeuticapplicationsintreatingdiseases
AT rojasmayorquinargeliae resveratrolanantiagingdrugwithpotentialtherapeuticapplicationsintreatingdiseases
AT ortunosahagundaniel resveratrolanantiagingdrugwithpotentialtherapeuticapplicationsintreatingdiseases
AT pallasmerce resveratrolanantiagingdrugwithpotentialtherapeuticapplicationsintreatingdiseases